Table II.
Performance characteristics of serum biomarkers for distinguishing pancreatic cancer from benign pancreatic diseases.
Markers | ROC area (%) | 95% CI | Sensitivity (%) | Specificity (%) |
---|---|---|---|---|
CA19-9 | 83.8a | (76.8–89.4) | 73.3 | 85.7 |
CA125 | 60.2a | (51.7–68.2) | 30.7 | 88.6 |
CA72-4 | 78.7a | (71.2–85.1) | 71.4 | 87.1 |
CA19-9 + CA72-4 | 89.5 | (83.3–94.0) | 70.6 | 92.8 |
P<0.05 compared with CA19-9 + CA72-4.
ROC, receiver operating characteristic; CI, confidence interval.